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Introduction
FGFs  comprise  a  family  of  22  polypeptides  that  regulate   
migration, proliferation, differentiation, and survival of different   
cell types. They exert these functions through activation of 
four  transmembrane  tyrosine  kinase  receptors,  designated 
FGF receptor (FGFR) 1–4 (Ornitz and Itoh, 2001; Beenken 
and Mohammadi, 2009). Further complexity is achieved by 
alternative splicing in the FGFR genes. Of particular impor-
tance is alternative splicing in the third immunoglobulin-like 
domain  of  FGFR1-3,  which  generates  IIIb  and  IIIc  vari-
ants  of  these  receptors  that  are  characterized  by  different   
ligand-binding specificities (Ornitz and Itoh, 2001). For example, 
the IIIb splice variant of FGFR2 (FGFR2IIIb) is a high-affinity 
receptor for FGF7, FGF10, and FGF22, whereas the IIIc variant 
(FGFR2IIIc) binds a variety of other FGF ligands (Zhang   
et al., 2006).
Previous studies revealed important roles of FGFs in 
development,  homeostasis,  and  repair  of  the  skin  (Steiling   
and Werner, 2003). Several FGFs are expressed in this tissue,   
and most of them are up-regulated upon injury (Werner et al.,   
1992,  1993;  Komi-Kuramochi  et  al.,  2005).  Of  particular   
interest are ligands of FGFR2IIIb because transgenic mice   
expressing  a  dominant-negative  mutant  of  this  receptor   
in  keratinocytes  showed  epidermal  atrophy,  hair  follicle   
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signaling in the latter. EGF activated these signaling pathways 
in cells of both genotypes (Fig. 1 D).
Overlapping functions of FGFR1  
and FGFR2 in the skin
Macroscopically, no obvious abnormalities were observed in   
K5-R1 mice at any stage of postnatal development (Fig. 2 B).   
In  contrast,  K5-R2  mice  revealed  a  phenotype  (Fig.  2  C) 
that fully matches the abnormalities seen in mice lacking   
FGFR2IIIb in keratinocytes (K5-R2IIIb mice; Grose et al., 
2007). The latter show hair abnormalities, a reduction in the 
number of hairs, and loss of sebaceous glands. The phenotype 
was much more severe in the double knockout mice (Fig. 2 D), 
whereas the loss of only one Fgfr2 allele in addition to both 
Fgfr1 alleles did not cause obvious phenotypic abnormal-
ities (not depicted). All females and 60% of the males were 
infertile, and both were much smaller than control littermates. 
They also progressively lost their hair and were hairless by 
the age of 2–4 mo (Fig. 2 E). However, we did not observe 
an increased mortality rate, and we were able to maintain the 
animals for up to 2 yr.
FGFR1IIIb cooperates with FGFR2IIIb in 
the regulation of epidermal homeostasis
To identify the splice variant that cooperates with FGFR2 in 
keratinocytes, we generated mice lacking FGFR1IIIb in all cells 
and FGFR2 in keratinocytes (K5-R2/R1IIIb mice). FGFR1IIIb-
deficient mice are phenotypically normal and do not display an 
obvious skin phenotype because only the IIIb exon of the Fgfr1 
gene was deleted in these mice, whereas all other FGFR1 splice 
variants are normally expressed (Zhang et al., 2004). The pheno-
type of K5-R2/R1IIIb mice was identical to the phenotype   
observed in K5-R1/R2 mice at the macroscopic (Fig. 2, E and F)   
and histological level (Fig. 3 E and not depicted). Therefore, 
we conclude that FGFR1IIIb and FGFR2IIIb cooperate in the 
regulation of epidermal homeostasis.
Loss of skin appendages and progressive 
acanthosis in K5-R1/R2 mice
We next focused on the phenotype of the double mutant mice. 
At P5 (first anagen), a mild hypotrophy of the epidermis was 
observed,  but  the  dermis  and  appendages  appeared  normal   
(Fig. 3 A). Although smaller and abnormally shaped, hair fol-
licles were still present at P18 (first telogen), and their number 
was similar to control mice (24 follicles/mm in control mice vs. 
25 follicles/mm in K5-R1/R2 mice; n = 6 control and 5 K5-
R1/R2 mice). At this stage, the epidermis had a normal thick-
ness, and no dermal abnormalities were observed (Fig. 3 B). 
By P30, control mice had entered the second anagen. However, 
most follicles from K5-R1/R2 mice were in telogen, although 
their number was still similar to the number in control mice   
(5 follicles/mm in mice of both genotypes; n = 4 control and   
3  K5-R1/R2  mice;  Fig.  3  C).  Hair  follicles  and  sebaceous 
glands were virtually absent in the back skin of older mice, 
and only a few cysts were present in the dermis (unpublished 
data), which demonstrates a progressive loss of appendages. 
Concomitantly,  fibrosis  developed  in  the  dermis  (Fig.  3  D). 
abnormalities,  and  impaired  wound  reepithelialization  (Werner 
et al., 1994). However, the responsible receptors remain to 
be  identified,  as  the  dominant-negative  mutant  blocks  the   
action  of  all  FGF  receptors  in  response  to  common  FGF   
ligands (Ueno et al., 1992). The abnormalities seen in these 
animals were not observed in FGF7 knockout mice (Guo et al., 
1996), which suggests functional redundancy among different 
FGFs and possibly FGF receptors. Indeed, expression studies 
revealed that FGF10 and FGF22 are also expressed in normal 
and wounded skin (Beer et al., 1997; Nakatake et al., 2001; 
Beyer et al., 2003). Together with FGF7, they can activate 
the “b” splice variants of FGFRs 1 and 2 (Zhang et al., 2006) 
that are expressed in keratinocytes (Beer et al., 2000; Zhang   
et al., 2004). In the case of FGF7 and FGF10, the activation   
occurs in a paracrine manner because both ligands are produced 
by fibroblasts in the dermal papilla and in the interfollicular   
dermis as well as by epidermal  T cells (Werner et al., 1993; 
Rosenquist and Martin, 1996; Jameson and Havran, 2007).   
In contrast, FGF22 is mainly expressed in the inner root sheath 
of the hair follicle (FGF22; Nakatake et al., 2001) and most 
likely acts in an autocrine manner (Fig.1 A).
To determine the function of these FGFs and their recep-
tors in the skin, we generated mice lacking FGFR1, FGFR2, 
or both receptors in keratinocytes. Our results revealed that 
these receptors cooperate to maintain the epidermal barrier 
and cutaneous homeostasis.
Results
Generation of mice lacking FGFR1, FGFR2, 
or both receptors in keratinocytes
Mice with floxed Fgfr1 (Pirvola et al., 2002) and Fgfr2 alleles 
(Yu et al., 2003) were mated with transgenic mice expressing 
Cre  recombinase  under  the  control  of  the  keratin  5  (K5)   
promoter. This promoter allows excision of floxed alleles in 
basal cells of stratified epithelia after embryonic day 15.5   
(Ramirez et al., 2004).
The progeny of our breeding included mice lacking FGFR1, 
FGFR2, or both receptors in keratinocytes (designated K5-R1, 
K5-R2, and K5-R1/R2 mice). Mice with floxed Fgfr alleles but 
without the Cre transgene were used as controls. Mice hetero-
zygous for the floxed alleles that express Cre were used as an 
additional control in some experiments, and they never revealed 
phenotypic abnormalities (unpublished data).
Real-time  RT-PCR  using  RNA  from  isolated  epidermis 
of control and mutant mice demonstrated a strong reduction of 
Fgfr1 and Fgfr2 expression (Fig. 1 B) in newborn single and 
double knockout mice, which further declined until postnatal day 
18 (P18; Fig. 1 B and not depicted). There was no compensatory 
up-regulation of Fgfr3 expression, and Fgfr4 mRNA could not 
be detected in mice of all genotypes using an RNase protection 
assay (Fig. 1 C).
When primary keratinocytes from P3 mice were stimulated 
with FGF7 or FGF10, efficient phosphorylation of FGFR sub-
strate 2 (FRS2), extracellular signal-regulated kinase 1/2 
(Erk1/2), and p38 was observed in cells from control but not from 
K5-R1/R2 mice, which demonstrates efficient inhibition of FGFR 937 Fibroblast growth factors in skin homeostasis and barrier function • Yang et al.
Figure 1.  Expression and activation of FGFR1IIIb and FGFR2IIIb in the skin of control and K5-R1/R2 mice. (A) The expression pattern of FGF7, FGF10, 
and FGF22 in the skin is shown schematically. FGF7 and FGF10 are expressed by fibroblasts of the dermis and the dermal papilla (DP) of the hair follicles 
and by epidermal  T cells. FGF22 is expressed by keratinocytes. These FGFs activate FGFR1IIIb and FGFR2IIIb on keratinocytes. Bar, 50 µm. (B) RNA 
from P0, P12, and P18 back skin epidermis of control and K5-R1/R2 mice was analyzed by real-time RT-PCR for the levels of Fgfr1 and Fgfr2 mRNAs. 
Error bars indicate mean ± SD. n = 3 K5-R1/R2 mice and 2 control mice at P0, n = 5 mice per genotype for P12 and P18. Glyceraldehyde 3-phosphate 
dehydrogenase (Gapdh) mRNA was used for normalization. Data are indicated as the percentage of control. (C) RNA was isolated from the epidermis 
of adult K5-R1/R2 mice and age-matched control mice. RNA from mouse liver was used as a positive control for FGFR4. Samples of 20 µg of RNA were 
analyzed by an RNase protection assay for expression of FGFR3, FGFR4, or GAPDH. b, bases. (D) Primary keratinocytes from control and K5-R1/R2 
mice were grown to confluency, serum-starved, and treated for 10 min with FGF7, FGF10, EGF, or medium without growth factors (medium). Lysates were 
analyzed by Western blotting using antibodies against total and phosphorylated signaling proteins or lamin A (loading control).JCB • VOLUME 188 • NUMBER 6 • 2010   938
although the loricrin-positive part of the epidermis was thicker 
in K5-R1/R2 animals. K6, which is restricted to hair follicle 
keratinocytes in normal skin, was abnormally expressed in the 
interfollicular  epidermis  of  adult  K5-R1/R2  mice  (Fig.  S1).   
Interfollicular  expression  of  this  keratin  is  characteristic  for 
hyperplastic and hyperproliferative skin. Overexpression of 
K6 was already seen at the RNA level at P18, but only a weak   
immunoreactivity was observed in the interfollicular epidermis 
at this time point (unpublished data).
Cell proliferation was assessed by in vivo labeling with 
BrdU. At  P18,  keratinocyte  proliferation  was  only  mildly   
increased in K5-R1/R2 mice (Fig. 4 B, left). At the age of 3 mo, 
however, keratinocyte proliferation was strongly increased in the 
back and tail skin of K5-R1/R2 mice but not of K5-R1 or K5-R2 
mice (Fig. 4, A and B, right; and not depicted). The increase in   
keratinocyte proliferation upon aging suggests that the hyper-
proliferation is not a cell-autonomous effect but results from the 
progressive inflammation. This hypothesis is supported by the 
normal in vitro proliferation rate of primary keratinocytes isolated 
from K5-R1/R2 mice at P3 (Fig. 4 C, left). Proliferation was 
even reduced in cells from P23 K5-R1/R2 mice compared with 
cells from control mice of the same age (Fig. 4 C, right).
Progressive skin inflammation in  
K5-R1/R2 mice
To test the possible role of inflammation in the hyperthickening 
of the epidermis, we analyzed the immune cells. The most obvious 
These abnormalities were reminiscent of the phenotype seen in   
K5-R2IIIb mice (Grose et al., 2007), but they were more   
severe in double knockout mice. In contrast to all single knock-
out mice, however, K5-R1/R2 as well as K5-R2/R1IIIb mice 
developed  epidermal  hyperthickening  (acanthosis)  combined 
with disorganization of the keratinocytes at the age of 2–3 mo, 
and this phenotype further progressed upon aging (Fig. 3, D 
and E). Acanthosis was seen in all areas of the skin and was 
particular severe in the tail skin (Fig. 3 E). This phenotype was 
unexpected because FGFs are potent mitogens for keratinocytes 
(Steiling and Werner, 2003). Therefore, we next focused on the 
mechanisms underlying the epidermal abnormalities and the 
progressive skin disease that developed in these mice.
Loss of FGFR1 and FGFR2 in 
keratinocytes causes hyperproliferation  
in vivo but not in vitro
Acanthosis may result from reduced apoptosis, impaired differ-
entiation, or enhanced proliferation of keratinocytes, and these 
possibilities were explored. Apoptotic cells were extremely rare 
in the epidermis of control or K5-R1/R2 mice (unpublished 
data). Immunofluorescence analysis of epidermal differentiation 
markers revealed appropriate expression of keratin 14 (K14) in 
the basal layer. K10 expression started in the first suprabasal 
layer in mice of both genotypes, but the number of K10-positive 
layers was increased in K5-R1/R2 mice. Loricrin was expressed 
in the granular and cornified layers in mice of all genotypes, 
Figure 2.  Macroscopic abnormalities in FGFR mutant mice. Photographs were taken from control (A), K5-R1 (B), K5-R2 (C), K5-R1/R2 (D and E), and   
K5-R2/R1IIIb (F) mice at the age of 1 mo (1M; A–D) or 5 mo (5M; E and F).939 Fibroblast growth factors in skin homeostasis and barrier function • Yang et al.
and  IL-1F8  in  the  epidermis  of  K5-R1/R2  mice,  whereas 
TNF and IL-1 expression was unaltered (Fig. 6 C and not   
depicted). However, S100A8, S100A9, and IL-1F8 were not   
up-regulated in cultured keratinocytes from K5-R1/R2 mice, 
neither in exponentially growing cells nor in quiescent cells that 
had undergone in vitro differentiation (unpublished data). This 
finding suggests that these cytokines are not directly regulated 
by the loss of FGFR1 and FGFR2, but rather through a pro- 
inflammatory stimulus that is only present in vivo. Alternatively, 
they may be produced by other cell types in the epidermis, e.g., 
by  T cells. To distinguish between these possibilities, we 
separated  T cells from other epidermal cells (predominantly 
keratinocytes) by FACS using dissociated cells from epidermal 
sheets (Fig. S3, B and C). The efficient enrichment of keratino-
cytes and  T cells was verified by semiquantitative RT-PCR 
analysis of mRNAs encoding K14 or the  T cell receptor, 
respectively (Fig. 6 D). Using RNAs from the purified cell 
populations, we found that S100A8/A9 are mainly produced 
difference that we observed by immunofluorescence was the 
strong (60%) increase in epidermal  T cells (Fig. 5 A). This 
was  verified  by  FACS  analysis  of  cells  from  isolated   
epidermis (unpublished data). Interestingly, the number of   
T cells was already significantly increased at P18, whereas no   
difference was observed at P12 (Fig. S2 A). The number of 
Langerhans cells was similar in control and K5-R1/R2 mice 
(unpublished data). Toluidine blue staining revealed signifi-
cantly more mast cells in the dermis of K5-R1/R2 mice at the 
age of 6 mo and P18, but no differences at P12 (Fig. 5 A  
and Fig. S2 B).
FACS analysis of dermal cells showed a significant increase 
in the number of CD45-positive immune cells, particularly  
and  T cells, in adult mice (Figs. 5 B and Fig. S3 A). This 
was confirmed by immunofluorescence, and an increased num-
ber of CD45-positive cells was already seen at P36 (Fig. S2 C).   
In contrast, no significant difference in the number of macro-
phages and neutrophils was detected using antibodies against   
CD11b and F4/80 or Ly-6G, respectively (Fig. 5 B and Fig. S3 A). 
The lack of a macrophage or neutrophil infiltrate was also con-
firmed by immunohistochemistry (unpublished data).
B cells do not accumulate in the skin, but their activation 
in adult K5-R1/R2 mice was demonstrated by the presence of 
enhanced levels of Igs G1, G2a, and E in the dermis and of IgE 
in the serum (Fig. 5 C).
These results demonstrate that the loss of FGFR1 and 
FGFR2  in  keratinocytes  initiates  an  inflammatory  response. 
This  is  also  reflected  by  enhanced  levels  of  phosphorylated   
(activated) and total nuclear factor B (NF-B) in the epidermis 
of aged mutant mice. Levels of total and phosphorylated STAT3 
were also higher compared with controls, whereas expression 
and activation of p38 were not affected (Fig. 6 A).
Real-time RT-PCR analysis of RNAs from dermis and   
epidermis of aged mice revealed enhanced expression of the 
pro-inflammatory cytokines TNF, interleukin-1 (IL-1), and   
of IL-1 family member 8 (IL-1F8), a new member of the IL-1   
family (Fig. 6 B; Barksby et al., 2007). We also found up-regulation   
of S100A8 and S100A9, which are expressed by activated   
keratinocytes in hyperproliferative epidermis of psoriatic patients 
and in epidermal skin cancers and which act as chemoattrac-
tants for inflammatory cells (Gebhardt et al., 2006). In addi-
tion, intercellular adhesion molecule 1 (ICAM-1) was strongly 
expressed in the dermis (Fig. 6 B). This reflects the progressive 
skin inflammation in K5-R1/R2 mice.
Role of keratinocyte- and  T cell–
derived cytokines in the initiation of the 
inflammatory response
To  identify  the  factors  that  initiate  the  inflammation  in   
K5-R1/R2 mice, we determined the expression of the above- 
mentioned cytokines at P18 using RNA from isolated epidermis.   
The efficient separation of epidermis from dermis was veri-
fied  by  RT-PCR  for  K14  (epidermal  marker)  and  vimentin 
(dermal marker; unpublished data). At P18, the loss of FGFR 
expression was almost complete (Fig. 1 B), but the epidermis 
was not yet hyperthickened (Fig. 3 B). We found a strongly 
increased expression of the genes encoding S100A8, S100A9, 
Figure  3.  Progressive  loss  of  skin  appendages  in  K5-R1/R2  mice.  
(A–D) Longitudinal paraffin sections from back skin of K5-R1/R2 female mice 
and control (ctrl) female littermates at P5, P18, 1 mo (1M), or 6 mo (6M) 
were stained with H/E. Bars, 100 µm. (E) Paraffin sections from the tail skin 
of control, K5-R1/R2, and K5-R2/FGFR1IIIb animals were stained with 
H/E. D, dermis; E, epidermis; HF, hair follicles. Bars, 22 µm.JCB • VOLUME 188 • NUMBER 6 • 2010   940
Magne et al., 2006). In addition, increased mRNA levels of 
TGF-, hepatocyte growth factor (HGF), and FGF7 were ob-
served in response to IL-1F8 treatment (Fig. 7 C). Most impor-
tantly, these mitogens were also overexpressed in the dermal 
compartment  of  K5-R1/R2  skin,  particularly  in  aged  mice, 
  together with granulocyte colony-stimulating factor (G-CSF; 
Fig. 7 D). Although the FGFR1/2-deficient keratinocytes can 
no longer respond to FGF7, the other growth factors are likely 
to contribute strongly to the hyperproliferative phenotype.
Epidermal barrier function is disturbed in 
K5-R1/R2 mice
Because cutaneous inflammation frequently results from a defect 
in epidermal barrier function (Segre, 2006), we analyzed the 
transepidermal water loss (TEWL) that reflects the status of the 
permeability barrier (Fluhr et al., 2006). At P18, TEWL was 
slightly increased in K5-R1/R2 mice. This phenotype strongly 
increased with age, and the TEWL was significantly higher in 
the double knockout mice compared with control animals at the 
age of 6 mo (Fig. 8 A). This is consistent with their high   
consumption of drinking water (unpublished data) as well as 
with the dry and fragile appearance of the skin.
Epidermal barrier function is conferred by the cornified 
envelope (Segre, 2006) and by tight junctions (Pummi et al., 2001; 
Brandner et al., 2002; Furuse et al., 2002; Langbein et al., 2002). 
by keratinocytes and up-regulated in this cell type in K5-R1/R2 
mice,  whereas  IL-1F8  was  predominantly  expressed  by    
T cells, particularly in the knockout mice (Fig. 6 D). Therefore, 
both keratinocytes and  T cells appear to contribute to the 
inflammatory phenotype.
IL-1F8 stimulates keratinocyte 
proliferation and production of  
keratinocyte mitogens by stromal cells
IL-1 released from keratinocytes is a potent inducer of keratino-
cyte mitogens in fibroblasts, resulting in keratinocyte prolifera-
tion through a double paracrine loop (Szabowski et al., 2000). 
To determine if IL-1F8 plays a similar role, we injected IL-1F8 
or BSA as a control intradermally into the skin of wild-type 
mice. 24 h later, increased keratinocyte proliferation was ob-
served in IL-1F8–injected mice as determined by BrdU labeling 
as well as by staining of skin sections with an antibody against 
proliferating cell nuclear antigen (PCNA; Fig. 7 A). To deter-
mine if this is a direct effect of IL-1F8 or mediated via stro-
mal cells, we treated murine keratinocytes with recombinant 
IL-1F8 at concentrations used in previous studies (Magne   
et al., 2006) and found a mild pro-mitogenic effect of this cyto-
kine (60% increase; Fig. 7 B). Treatment of serum-starved   
murine fibroblasts with IL-1F8 induced the expression of IL-6 
and IL-8, as described previously (Fig. 7 C and not depicted;   
Figure  4.  Enhanced  keratinocyte  prolifera-
tion in aged K5-R1/R2 mice in vivo but not   
in vitro. K5-R1/R2 mice and control littermates 
were injected with BrdU at P18 or 3 mo of 
age. Tail skin sections were stained with a 
peroxidase-conjugated antibody against BrdU. 
(A) Representative sections from 3-mo-old mice 
are  shown.  Bars,  100  µm.  (B)  The  number 
of BrdU-positive cells/mm of basement mem-
brane was counted using at least 10 sections 
per mouse. Error bars indicate mean ± SD.   
n = 8 control and 6 K5-R1/R2 mice for P18; 
n = 4 control and 6 K5-R1/R2 mice for 3 mo 
(3M). *, P ≤ 0.05; **, P ≤ 0.005. (C) Primary 
keratinocytes  of  control  and  K5-R1/R2  mice 
were isolated at P3 or P23, seeded at equal 
density, and labeled with BrdU. The percent-
age  of  BrdU  positive  cells  was  determined. 
Error bars indicate mean ± SD. n = 4 per 
  genotype for P3 and n = 3 for P23. At least 
two microscopic areas were counted per dish.941 Fibroblast growth factors in skin homeostasis and barrier function • Yang et al.
Figure 5.  Immune cell infiltrate in the skin of K5-R1/R2 
mice. (A) Back skin sections from 6-mo-old (M6) con-
trol and K5-R1/R2 mice were stained with antibodies 
against the  T cell receptor. The white dotted line in-
dicates the basement membrane. In addition, sections 
were stained with toluidine blue to identify mast cells. 
The number of  T cells and mast cells/mm of basement 
membrane was counted using at least five sections per 
mouse. n = 5 mice per genotype for  T cells and 7 mice   
per genotype for mast cells. Bar, 33 µm. (B) Cells from 
the dermis of 12-mo-old mice were analyzed by FACS 
using  antibodies  against  different  inflammatory  cell 
markers. n = 4 mice per genotype. The frequencies of 
the individual inflammatory cells are shown. Original 
FACS data are shown in Fig. S3 A. (C) Dermal pro-
tein lysates (n = 3 control and 4 K5-R1/R2 mice) or 
serum (n = 3 per genotype) of mice at the age of 12 mo 
were analyzed for the levels of IgG1, IgG2a, and IgE 
by ELISA. Error bars indicate mean ± SD. *, P ≤ 0.05; 
**, P ≤ 0.005.JCB • VOLUME 188 • NUMBER 6 • 2010   942
Figure 6.  Progressive inflammation in the skin of K5-R1/R2 mice through production of cytokines by activated keratinocytes and  T cells. (A) Epidermal 
lysates from control and K5-R1/R2 mice at the age of P18 and 5 mo (5M) were analyzed by Western blotting for the levels of phosphorylated and total 
NF-B (p65), Stat3, Erk1/2, and p38. (B) RNAs from isolated dermis and epidermis of K5-R1/R2 mice and littermate controls (8M) were analyzed for 
expression of inflammatory markers using real-time RT-PCR. Gapdh mRNA was used for normalization. Results are shown in the table. , not detectable; 
+, weak expression; ++, moderate expression; +++, strong expression. (C) RNAs from the epidermis of K5-R1/R2 mice and littermate controls at P18 
were analyzed for expression of inflammatory markers using real-time RT-PCR. Gapdh mRNA was used for normalization. Error bars represent mean ± SD.   
n = 3 per genotype. *, P ≤ 0.05; **, P ≤ 0.005; ***, P ≤ 0.001. (D) Keratinocytes and  T cells were purified from epidermal sheets by preparative 
FACS. Original FACS data are shown in Fig. S3 (A and B). RNAs from the purified cell populations were analyzed by RT-PCR for the expression of S100A8, 
S100A9, and IL-1F8. Ribosomal protein S29 (RPS29) mRNA was used for normalization; expression of keratin 14 and of the  T cell receptor was ana-
lyzed to verify the enrichment of the two cell populations.
Expression of loricrin was enhanced in the knockout mice 
(Fig. S1), and the mRNA levels of SPRR2A, another compo-
nent  of  the  cornified  layer,  were  up-regulated  >30-fold   
(unpublished data). In contrast, expression of tight junction 
components was strongly reduced. The mRNA levels of clau-
din 3, claudin 8, and occludin were much lower in K5-R1/R2 
mice, as determined by real-time RT-PCR analysis of epider-
mal RNAs (Fig. 8 B). A strong down-regulation was already 
seen at P12 (2–18% of control). Western blot analysis of epi-
dermal lysates confirmed the down-regulation of claudin 3 
and occludin at the protein level and also revealed reduced 
claudin-1 expression in K5-R1/R2 mice (Fig. 8 C). Impor-
tantly, the down-regulation of tight junction gene expression 
preceded the onset of inflammation and hair loss, which strongly 
suggests that this is a direct consequence of the loss of FGFR1 
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To determine if the down-regulation of claudin/occludin 
expression is a cell-autonomous effect, we analyzed the ex-
pression of these tight junction components in immortalized 
keratinocytes. Indeed, a strong down-regulation was observed 
in three independent cell lines from K5-R1/R2 mice compared 
with controls (Fig. 9, A–C). When confluent keratinocytes from 
wild-type mice were stimulated with FGF7, a slight increase in 
the levels of occludin and a stronger increase in claudin 1 and 
claudin 3 were observed, which indicates that these genes are 
targets of FGFs in keratinocytes (Fig. 9 B). Their regulation   
occurs at the RNA level because the mRNA levels of claudin 1 
and claudin 3 were 5- or 30-fold elevated in FGF7-treated   
As a consequence of the down-regulation of tight junc-
tion  gene  expression,  only  a  rudimentary  development  of 
tight junctions was observed in the epidermis of K5-R1/R2 
mice  using  transmission  electron  microscopy  (Fig.  8  E), 
whereas tight junctions were well developed in control mice 
(Fig. 8 D). In most of the sections from adult K5-R1/R2 ani-
mals, we also found bubble-like intercellular clefts between 
the  keratinocytes  of  the  stratum  granulosum,  which  most 
likely result from water-filled cavities (Fig. 8 F). Enlarge-
ment of the intercellular gaps was already seen occasionally 
in mutant mice at P18, and the phenotype progressed upon 
aging (unpublished data).
Figure 7.  IL-1F8 stimulates keratinocyte proliferation and production of keratinocyte mitogens by fibroblasts. (A) IL-1F8 or BSA were intradermally injected 
into wild-type mice. 24 h later, proliferating cells were identified by BrdU labeling or by immunostaining with an antibody against PCNA. Bars, 33 µm.   
(B) Immortalized keratinocytes from wild-type mice were treated with 500 ng/ml IL-1F8 for 2 h and labeled with BrdU. The percentage of BrdU-positive cells 
was determined. Error bars indicate mean ± SD; n = 3. (C) Immortalized embryonic fibroblasts were starved overnight in medium with 0.1% FCS and sub-
sequently treated for 15 min or 3 h with 500 ng/ml IL-1F8. RNA was isolated from these cells before and after IL-1F8 treatment and analyzed by real-time 
RT-PCR for the mRNA levels of different keratinocyte mitogens as indicated. Gapdh mRNA was used for normalization. Bars represent means from duplicate 
determinations. The IL-1F8–induced expression of keratinocyte mitogens was reproduced with an independent fibroblast cell line. (D) RNA from the dermis 
of 8-mo-old (8M) control and K5-R1/R2 mice was analyzed by real-time RT-PCR for the mRNA levels of different keratinocyte mitogens as indicated. RPS29 
mRNA was used for normalization. Error bars represent mean ± SD. n = 3 per genotype (5 for TGF-). *, P ≤ 0.05; **, P ≤ 0.005; ***, P ≤ 0.001.JCB • VOLUME 188 • NUMBER 6 • 2010   944
Figure 8.  Impaired barrier function in K5-R1/R2 mice. (A) TEWL was determined in control and K5-R1/R2 mice at the age of P18 or 5 mo (5M). Error 
bars indicate mean ± SD. n = 6 control mice at P18 and 9 K5-R1/R2 mice at P18; n = 4 mice per genotype at 5M. *, P ≤ 0.05. (B) RNA from isolated 
epidermis of mice at P12, P18, or 8 mo was analyzed by real-time RT-PCR for expression of different claudins and occludin. RPS29 mRNA was used   
for normalization. n = 3–5 per time point and genotype. Expression in control mice was arbitrarily set as 100%. Error bars represent mean ± SD. 
(*), 0.05 < P < 0.06; *, P ≤ 0.05. (C) Epidermal lysates of control and K5-R1/R2 mice (P18 or 8 mo old [8M]) were analyzed by Western blotting for the 945 Fibroblast growth factors in skin homeostasis and barrier function • Yang et al.
purpose, we measured the transepithelial electrical resistance 
(TER)  of  confluent  immortalized  keratinocytes  from  control 
and K5-R1/R2 mice because tight junctions restrict paracellular 
diffusion of ions. Indeed, the TER was reduced by >50% in 
three independent cell lines from FGFR-deficient mice com-
pared with control mice (Fig. 9 D and not depicted). The   
same difference was observed on several consecutive days   
(unpublished data).
Taken together, our results suggest that reduced expres-
sion of several tight junction components disrupts the epidermal 
keratinocytes compared with nontreated cells (unpublished data). 
EGF also induced their expression under these conditions (un-
published data), but it can obviously not compensate for the loss 
of FGF receptors because expression of claudin 1, claudin 3, 
and occludin was reduced in keratinocytes of K5-R1/R2 mice, 
which were cultured in the presence of EGF (Fig. 9 B).
Finally, we determined if the reduction in claudin/occludin 
expression is functionally important. Because of the lack of 
a functional assay to determine tight junction permeability in 
adult  mice,  we  addressed  this  question  in  vitro.  For  this   
levels of claudin 1, claudin 3, occludin, and total ERK (loading control). (D–F) High-magnification ultrastructure revealed a typical desmosome–tight junction 
(arrow) complex between keratinocytes of the stratum granulosum in a 4-mo-old control mouse (D), whereas only a rudimentary cell–cell contact is formed 
adjacent to a desmosome of a 4-mo-old K5-R1/R2 mouse (E). In these animals, bubble-like clefts (asterisk) were frequently seen between the keratinocytes 
in the stratum granulosum, particularly in aged mice (F, 6-mo old mouse). D, desmosome. Bars: (D and E) 150 nm; (F) 250 nm.
 
Figure 9.  Reduced expression of tight junction proteins in cultured keratinocytes from K5-R1/R2 mice reduces the TER. (A) RNAs from cultured, immortal-
ized keratinocytes of control and K5-R1/R2 mice were analyzed by real-time RT-PCR for expression of different claudins and occludin. RPS29 mRNA was 
used for normalization. Bars represent means from duplicate determinations. The down-regulation of these tight junction components in K5-R1/R2 cells 
was reproduced with two independent cell lines from control and mutant mice. (B) Cultured keratinocytes of control and K5-R1/R2 mice were starved for 
24 h and incubated for 96 h in starvation medium with or without FGF7. Lysates were analyzed by Western blotting for expression of claudin 1, claudin 
3, occludin, or GAPDH (loading control). (C) Cultured primary keratinocytes were grown to confluency and analyzed for the expression of claudin 3 by 
immunofluorescence (green). Bars, 33 µm. (D) TER was measured using immortalized keratinocytes from control and K5-R1/R2 mice that had been grown 
to confluency and incubated in differentiation medium until stable values were obtained. A representative measurement is shown using six independent 
filters with cells from each genotype. Error bars represent mean ± SD. The result was reproduced at different days and with two independent cell lines from 
control and K5-R1/R2 mice. **, P ≤ 0.005JCB • VOLUME 188 • NUMBER 6 • 2010   946
dermal papilla during the transition from early to late telogen. 
Functional in vitro studies suggested that this results in stimula-
tion of hair germ cells adjacent to the papilla and subsequent hair 
cycle activation (Greco et al., 2009). The failure of K5-R1/R2 mice 
to regenerate hair follicles is fully consistent with this predicted 
function. The reason for the subsequent hair loss is presently 
unclear. It may well be that the progressive inflammation con-
tributes to this phenotype, but this needs to be further studied 
in the future.
Keratinocyte hyperproliferation in K5-R1/R2 
mice is mediated via the stroma
A  particularly  striking  and  unexpected  phenotype  of  the   
K5-R1/R2 mice is the progressive acanthosis, which results 
from enhanced proliferation of keratinocytes. This was surpris-
ing because FGFs are potent mitogens for keratinocytes, and   
because epidermal hypotrophy was observed in the skin of   
newborn mice lacking FGFR2IIIb in all cells (Petiot et al., 2003) 
as well as in the skin of adult mice expressing a dominant- 
negative FGFR2IIIb mutant in keratinocytes (Werner et al., 
1994). In fact, we also observed a slight epidermal hypotrophy 
in very young K5-R1/R2 mice (Fig. 3 A), but this reversed upon 
aging, and the reversal correlated with the onset of inflamma-
tion. Therefore, we propose that loss of FGFRs in keratinocytes   
results in activation of immune cells, which subsequently disrupts 
cutaneous homeostasis.
FGFs regulate tight junction components
Several mechanisms may be responsible for the activation of 
immune cells, including direct FGF-mediated suppression of 
pro-inflammatory cytokine expression, inflammation mediated 
by degenerating hair follicles, or a defect in barrier function that 
results in dry skin and possibly invasion of irritants/allergens   
and  bacteria.  The  first  possibility  seems  unlikely  because   
expression levels of S100A8/A9 and IL-1F8 were similar in 
cultured keratinocytes from mice of both genotypes. Inflamma-
tion as a result of hair follicle degeneration has been postulated 
for  mice  lacking  1  integrins  in  keratinocytes  (Brakebusch   
et al., 2000). However, the macrophage infiltrate around the 
hair follicles that was seen in 1 integrin-deficient mice was 
not observed in K5-R1/R2 animals. Furthermore, the phenotype 
progressed upon loss of all follicles, which indicates that de-
generating follicles are not or at least not exclusively responsible 
for the development of skin inflammation. Therefore, the most 
likely explanation for the skin inflammation is the defect in the 
epidermal  barrier.  Surprisingly,  expression  of  several  genes   
involved in the formation of the cornified envelope was even   
increased (unpublished data). This was also the case for filaggrin,   
a gene that is mutated in a large percentage of patients with 
atopic dermatitis (Sandilands et al., 2009). In addition, the   
filaggrin protein was normally processed in K5-R1/R2 mice 
(unpublished data). In contrast, expression of several claudins 
and  of  occludin  was  much  lower  in  the  epidermis  and  in   
cultured keratinocytes of K5-R1/R2 mice. The reduced TER in   
vitro as well as the increased TEWL in vivo strongly suggest that 
the down-regulation of these tight junction components is func-
tionally important. Consistent with this hypothesis, changes in 
barrier, resulting in activation of keratinocytes and  T cells. 
To further test this hypothesis, we determined if disruption of 
the epidermal barrier causes a similar phenotype. Treatment 
of wild-type mice with acetone, which damages the epidermal 
barrier,  caused  the  expected  hyperproliferation  of  keratino-
cytes (Fig. 10 A; Proksch et al., 1991). Similar to the case of   
K5-R1/R2 mice, this was associated with a minor increase in the 
number of mast cells and with a significant increase in epider-
mal  T cells (Fig. 10 A). In a complementary experiment, we 
tested if treatment of the skin of K5-R1/R2 mice with a moistur-
izing cream ameliorates the phenotype. Although we could not   
observe a reduction in keratinocyte proliferation, the number of 
mast cells and of  T cells was significantly reduced (Fig. 10 B).   
Concomitantly,  expression  of  IL-1F8  was  reduced  by  30%, 
whereas  no  obvious  change  in  the  expression  of  claudin  1,   
claudin 3, or occludin was observed (unpublished data).
Together, these findings support the hypothesis that a   
defect in the epidermal barrier initiates and maintains the   
cutaneous inflammatory response in K5-R1/R2 mice. This   
induces  keratinocyte  hyperproliferation  through  a  double   
paracrine loop involving  T cell–derived IL-1F8, keratino-
cyte-derived S100A8 and A9, and several keratinocyte mitogens 
produced by dermal cells (summarized in Fig. 10 C).
Discussion
Cooperative functions of FGFR1 and 
FGFR2 in keratinocytes
We  identified  essential  roles  of  FGFR1IIIb  and  FGFR2IIIb 
in the maintenance of skin appendages and epidermal barrier 
function. The responsible ligands are most likely FGF1, FGF7, 
FGF10, and FGF22, which are expressed in different com-
partments of the skin (Steiling and Werner, 2003). Our results 
identified FGFR2IIIb as the most important receptor for these   
ligands in keratinocytes, whereas FGFR1IIIb provides a back-up   
function. FGFR3 is also expressed in keratinocytes, particularly 
in the suprabasal layers (Logié et al., 2005). However, it binds 
a different set of FGFs than FGFR1IIIb and FGFR2IIIb (Zhang 
et al., 2006), which suggests distinct functions. Although mice 
lacking FGFR3 have no obvious skin abnormalities (unpublished 
data), it will be interesting to determine the consequences of the 
loss of all FGF receptors in keratinocytes.
Loss of FGFR1 and 2 in keratinocytes 
impairs hair regeneration
The loss of skin appendages that we observed in K5-R1/R2 
mice is consistent with the stimulatory effect of FGF7 on hair   
follicle growth, development, and differentiation (Danilenko et al., 
1995). However, only a rough hair coat but no hair loss was seen 
in FGF7-deficient animals (Guo et al., 1996), which indicates 
functional redundancy among FGF family members. It seems 
likely that FGF7 together with FGF10 and FGF22 cooperatively 
orchestrate hair regeneration via activation of FGFR1IIIb and 
FGFR2IIIb on hair follicle keratinocytes. This hypothesis is fur-
ther supported by the up-regulation of these FGFs in the anagen 
phase of the hair cycle (Kawano et al., 2005). It was recently 
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Figure 10.  The epidermal barrier controls the number of mast cells and  T cells. (A) Topical treatment of wild-type mice with acetone enhanced   
keratinocyte proliferation and increased the number of mast cells and  T cells. (B) Topical treatment of K5-R1/R2 with moisturizing cream did not affect 
keratinocyte proliferation, but reduced the number of mast cells and of  T cells. Error bars indicate mean ± SD. n = 7 mice for acetone and 5 mice for 
moisturizing cream treatment. (C) Model describing the pathogenic mechanisms in the skin of K5-R1/R2 mice. Loss of FGFR signaling in keratinocytes 
results in reduced expression of tight junction components. The resulting defective epidermal barrier, together with the loss of sebaceous glands, causes 
skin dryness. This activates a stress response in keratinocytes, resulting in activation of  T cells and up-regulation of cytokine expression in activated  
T cells and keratinocytes. The latter stimulate keratinocyte proliferation directly (IL-1F8) and/or indirectly (IL-1F8 and S100A8/A9) through induction of a 
double paracrine loop involving several keratinocyte mitogens that are produced by stromal cells. In addition, invasion of foreign antigens and pathogens 
may further activate immune cells and accelerate the inflammatory response. *, P ≤ 0.05; **, P ≤ 0.005.JCB • VOLUME 188 • NUMBER 6 • 2010   948
hyperproliferative phenotype through an intra-epidermal paracrine 
mechanism. Most importantly, it induced the expression of keratino-
cyte mitogens in fibroblasts. This is likely to be relevant for the 
in vivo situation because these mitogens were overexpressed in the 
dermis of K5-R1/R2 mice. Preliminary results also showed that 
intradermal injection of IL-1F8 induces expression of the same 
growth  factors  in  vivo.  Their  up-regulation  may  then  further   
promote  keratinocyte  hyperproliferation  in  a  paracrine  manner. 
The role of IL-1F8 in the induction of the hyperproliferative pheno-
type is consistent with the cutaneous inflammation, hyperkeratosis, 
and acanthosis seen in transgenic mice overexpressing IL-1F6 
in keratinocytes (Blumberg et al., 2007). Because IL-1F6 and 
IL-1F8 signal through the same receptors (Towne et al., 2004), 
the results from Blumberg et al. (2007) and from our study identify 
the novel IL-1 family members as major players in inflammatory/
hyperproliferative skin disease.
In summary, our study revealed novel roles of FGFR1 and 
FGFR2 in epidermal barrier function and cutaneous homeostasis   
through  their  regulation  of  tight  junction  components.  The   
importance of the latter in human skin disease associated with 
hyperscaling and acanthosis is emerging, as reflected by the 
ichthyosis phenotype seen in patients with a claudin 1 muta-
tion (Hadj-Rabia et al., 2004) and by the abnormal expression/ 
distribution  of  tight  junction  proteins  in  psoriasis  (Peltonen   
et al., 2007; Watson et al., 2007; Kirschner et al., 2009).   
Future studies will reveal if abnormal expression of FGFs and/or 
FGF receptors and their tight junction targets is associated with 
inflammatory skin diseases such as atopic dermatitis, which is 
also characterized by impaired barrier function (Proksch et al.,   
2006; Elias and Steinhoff, 2008) and which shows several 
similarities with the phenotype of K5-R1/R2 mice, particularly 
with regard to the inflammatory infiltrate and the epidermal 
thickening. In addition, the data presented in this manuscript 
suggest new therapeutic applications of FGFs in patients with 
impaired epidermal barrier function.
Materials and methods
Generation and maintenance of mice lacking FGFR1 and/or FGFR2  
in keratinocytes
Fgfr1
flox/flox mice were mated with Fgfr2
flox/flox mice (provided by A. Ramirez 
and J. Jorcano, Centro de Investigaciones Energéticas, Medioambientales y 
Tecnológicas, Madrid, Spain). After two generations of breeding, the   
Fgfr1
flox/flox/Fgfr2
flox/flox mice were mated with K5
cre/wt transgenic mice. The 
male Fgfr1
flox/wt/Fgfr2
flox/wt K5
Cre/wt mice obtained from this mating were 
then crossed with the Fgfr1
flox/flox/Fgfr2
flox/flox female mice. In addition, mice 
lacking FGFR1IIIb in all cells (provided by L.T. Williams, FivePrime Therapeu-
tics, San Francisco, CA) were mated with Fgfr2
flox/flox and K5
cre/wt. All mice 
were in a C57BL/6 genetic background. Mice were housed and fed accord-
ing  to  Swiss  federal  animal  protection  guidelines.  All  procedures  were   
approved by the local veterinary authorities of Zurich, Switzerland.
Identification of genetically modified mice by PCR
The floxed Fgfr1 allele was detected by genotyping PCR using primers   
5-CGAATGGACAAGCCCAGTAAC-3 and 5-CTCCTGCTTCCTTCAG-
AGC-3. PCR products of 200 bp or 300 bp were obtained for the   
wild-type or floxed allele, respectively.
Genotyping PCR for the Fgfr2 floxed allele was performed using 
primers  FGFR2F5  (5-ATAGGAGCAACAGGCGG-3)  and  FGFR2F3   
(5-TGCAAGAGGCGACCAGTCAG-3).  PCR  products  of  140  bp  or   
200 bp were obtained for the wild-type or floxed alleles, respectively. The 
recombined allele was identified using primers FGFR2F5 and FGFR2rec   
(5-CATAGCACAGGCCAGGTTG-3). A 470-bp fragment was obtained.
the tight junction composition affected their permeability (Inai 
et al., 1999; Furuse et al., 2002; Tunggal et al., 2005). Unfortu-
nately, functional in vivo assays, such as biotin penetration, can 
only be performed in newborn mice, where the phenotype was 
not sufficiently developed. Therefore, a final proof for an in vivo 
deficit in tight junction permeability will await improved in vivo 
assays. Nevertheless, the rudimentary development of the tight 
junctions and the adjacent large gaps between the keratinocytes 
of the granular layer that we observed by electron microscopy 
strongly support our hypothesis of an increased tight junctional 
permeability that results in severe water loss. Down-regulation 
of tight junction proteins was already observed at P12, whereas 
enhanced water loss was only seen after P18. It may well be that 
a certain threshold of tight junction protein down-regulation 
must be reached to allow significant water loss. In addition, we 
found that expression levels of claudins and occludin strongly 
declined in control mice after P18 (Fig. S4). Therefore, a further 
loss in K5-R1/R2 mice might have more severe consequences 
in adults compared with young mice.
The down-regulation of tight junction gene expression in 
cultured keratinocytes from K5-R1/R2 mice together with the 
increased expression of these genes in wild-type keratinocytes 
in response to FGF7 treatment indicates that they are targets of 
FGFs. These results are consistent with the reduced expression 
of tight junction proteins in blood vessels and the defective 
blood–brain barrier function in FGF2/FGF5 double knockout 
mice (Reuss et al., 2003), with the FGF2-mediated preservation 
of the composition of tight junctions in organotypic cortical   
cultures of mice (Bendfeldt et al., 2007), and with the disassem-
bly of adherens and tight junctions in endothelial cells upon   
inhibition of FGFR signaling (Murakami et al., 2008). These 
findings indicate that maintenance of junctional integrity is a 
general but as yet poorly characterized function of FGFs.
Keratinocyte hyperproliferation is mediated 
via the stroma
The enhanced water loss seen in K5-R1/R2 mice resulted in   
severe skin dryness and fragility, which is likely to be aggra-
vated by the loss of sebaceous glands that release the mois-
turizing  sebum.  It  was  previously  shown  that  low  humidity 
stimulates keratinocyte proliferation and amplifies the hyper-
proliferative response to barrier disruption, causing dermal 
mast cell hypertrophy, their degranulation, and subsequent 
inflammation (Denda et al., 1998). In addition, it is likely to 
stress and damage keratinocytes, which results in activation and   
proliferation of  T cells (Jameson and Havran, 2007; Strid 
et al., 2009). The role of an impaired barrier and subsequent   
dryness in the skin phenotype is supported by the results ob-
tained with acetone-treated wild-type mice and by the beneficial 
effect of moisturizing cream on the inflammatory phenotype 
of K5-R1/R2 mice. In addition, it may well be that irritants/ 
allergens and bacteria can invade the dry and fragile skin,   
particularly at sites of minor injury, which results in immune 
cell activation and enhancement of the inflammatory response.
One of the responsible inflammatory mediators is most likely 
IL-1F8. We identified this cytokine as a keratinocyte mitogen, 
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starved overnight in medium without supplements and subsequently treated 
for 24 h with 10 ng/ml FGF7 (R&D Systems). Lysates were obtained before 
and after FGF7 treatment and analyzed by Western blotting for expression 
of tight junction components.
Measurement of TER
Three different immortalized keratinocyte lines from control and K5-R1/R2 
mice were grown to confluency on permeable supports (Costar Snapwell; 
Sigma-Aldrich) with 0.4-µm polycarbonate filter membranes in keratino-
cyte growth medium and subsequently cultured in differentiation medium 
(1:1  DME/F-12  supplemented  with  10%  FCS,  penicillin/streptomycin, 
0.1 nM cholera toxin, 2 nM T3, 5 µg/ml transferrin, 0.4 µg/ml hydro-
cortisone, 25 µg/ml gentamycin, 5 µg/ml insulin, and 10 ng/ml EGF) 
for 7–14 d. TER measurements were performed daily using an epithelial 
tissue volt ohmmeter (World Precision Instruments) as described previously 
(Balda et al., 1996). For each cell line, 3–6 filters were analyzed daily.
Cell culture
Keratinocytes were isolated from pools of mice with different genotypes, as 
described previously (Braun et al., 2002), with the exception that cells 
were seeded at a density of 5 × 10
4 cells/cm
2 on collagen IV (2.5 µg/cm
2; 
Sigma-Aldrich)-coated dishes. The freshly isolated cells were incubated for 
30 min at 37°C. Thereafter, the medium was replaced and cells were 
grown in defined keratinocyte serum-free medium (Invitrogen) supple-
mented with 10 ng/ml EGF and 10
10 M cholera toxin.
Analysis of FGF receptor-mediated signaling
Keratinocytes were suspended in defined keratinocyte medium at a cell 
density of 5 × 10
5 cells/ml and seeded in 6-well plates (400 µl/well). After 
overnight incubation, they were starved in defined medium without supple-
ments for 24 h and then treated for 10 min with 10 ng/ml FGF7, FGF10, 
or 20 ng/ml EGF (all from R&D Systems). Cells were harvested on ice and 
analyzed by Western blotting for the levels of signaling proteins and their 
phosphorylated forms.
RNA isolation and RNase protection assay
RNA isolation and RNase protection assays were performed as described 
previously (Werner et al., 1994). Fgfr3 and Fgfr4 cDNAs were used as 
templates (Steiling et al., 2003).
Real-time RT-PCR
Real-time RT-PCR was performed according to the manual of the Light 
Cycler 480 (Roche). The reverse transcription product obtained from 
0.5 ng RNA was used together with 10 µl of SYBRGreen reaction mix. 
The reaction was performed in 50 cycles (95°C for 10 min for initial 
denaturation; 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s for each 
cycle). Duplicate determinations were performed for each sample.
Primers used for RT-PCR
See Table II for the primers used.
Histological analysis
Skin samples were fixed overnight in 95% ethanol/1% acetic acid or in 4% 
PFA/PBS followed by paraffin embedding. Sections (7 µm) were stained 
with hematoxylin/eosin (H/E).
Quantification of hair follicles in mouse back skin
Hair follicles in the back skin were quantified by counting the number of dermal 
papillae in sections at 100× magnification. Seven serial images were counted 
for mice at P18, and 18 serial images were counted for mice at P36.
Electron microscopy
Mice were lethally anesthetized with 700 mg/kg pentobarbital and   
perfused with 4% PFA in PBS. Skin samples were kept overnight in fixation 
solution, then rinsed and stored in PBS. After washing in 0.1 M cacodylate 
buffer, pH 7.2, at 4°C, the specimens were either directly treated with 2% 
OsO4 for 2 h or first incubated in 1% tannin for 3 h and then treated with 
2% OsO4 for 2 h. After washing, they were stained in 1% uranyl acetate, 
dehydrated through series of graded ethanols, and embedded in araldite 
resin. Ultrathin sections (30–60 nm) were processed with a diamond knife 
and  placed  on  copper  grids.  Transmission  electron  microscopy  was   
performed using a 902A electron microscope (Carl Zeiss, Inc.).
Immunofluorescence and immunohistochemistry
After deparaffinization, skin sections were blocked with PBS containing 
3% BSA and 0.025% NP-40 for 1 h at room temperature, then incubated   
overnight at 4°C with the primary antibodies diluted in the same buffer. After 
The  K5-Cre  transgene  was  amplified  using  primers  5-AACAT-
GCTTCATCGTCGG-3 and 5-TTCGGATCATCAGCTACACC-3. A 420-bp   
fragment was obtained with DNA from transgenic mice.
Analysis of TEWL
Mice were shaved, and, after 30 min, TEWL was determined using a Tewame-
ter (Courage and Khazaka Electronic GmbH). The device was placed on the 
dorsal skin of mice, and 30 consecutive measurements were taken from four 
different places on the back as described by the manufacturer.
Separation of dermis and epidermis
Mice were sacrificed, then washed in 10 mM iodine solution, followed by 
70% ethanol and PBS, and a piece of back skin was excised. It was washed 
in gentamycin solution (1:200; Sigma-Aldrich) and then floated in dispase 
solution (Invitrogen) in defined keratinocyte serum-free medium (Invitrogen), 
including defined keratinocyte growth supplements for 2 h at 37°C. The epi-
dermal sheet was peeled off from the dermal layer using fine forceps. Iso-
lated dermis and epidermis were immediately frozen in liquid nitrogen and 
used for the isolation of RNA or preparation of protein lysates.
FACS analysis of cells from isolated dermis or epidermis and preparative 
sorting of keratinocytes and  T cells
Dermis and epidermis from mouse back skin were separated after overnight 
incubation in 0.2% trypsin in DME at 4°C. The epidermis was cut into small 
pieces and incubated for 20 min at 37°C in 0.2% trypsin in DME. The dermis 
was treated with DME containing 2.5 mg/ml collagenase II (Worthington 
Biochemical Corporation), 2.5 mg/ml collagenase IV (Invitrogen), 0.5 mg/ml 
DNase I (Sigma-Aldrich), and 1 mg/ml hyaluronidase (Worthington Bio-
chemical Corporation). A single cell suspension was prepared by passing 
the mix through a 70-µm strainer. DME/10% FCS was added to inactivate 
trypsin. Cells were washed with FACS buffer (PBS/0.2% BSA/5 mM EDTA), 
and an unspecific antibody binding was blocked with anti-CD32.
For preparative sorting of keratinocytes and  T cells, cells were 
stained for  T cell receptor, CD-45, and 7-amino-actinomycin D to deter-
mine viability. Analysis was performed using a cell sorter (Aria; BD). The 
fraction costained for the  T cell receptor and for CD45 contains pre-
dominantly  T cells, and the fraction that was negative for both markers 
consists predominantly of keratinocytes. RNA was isolated from the sorted 
cells using the RNeasy Micro kit (QIAGEN). cDNA was generated with the 
High-Capacity cDNA Reverse Transcription kit (Applied Biosystems).
Antibodies used for FACS
See Table I for the antibodies used.
Intradermal injection of IL-1F8
Wild-type mice were intradermally injected with 50 µl of a solution of 1 µg/ml 
IL-1F8 (R&D Systems) in 0.1% BSA in PBS or vehicle control. 24 h later,   
proliferating cells were analyzed using BrdU labeling as described below.
BrdU incorporation assay
Mice  were  injected  intraperitoneally  with  BrdU  (250  mg/kg  in  0.9% 
NaCl; Sigma-Aldrich) and sacrificed 2 h after injection. Skin samples were 
fixed in 95% ethanol/1% acetic acid. Sections were incubated with a   
peroxidase-conjugated monoclonal antibody directed against BrdU (Roche) 
and stained with diaminobenzidine.
Analysis of tight junction protein expression in cultured keratinocytes
Primary keratinocytes from control and K5-R1/R2 mice were grown to con-
fluency in defined keratinocyte growth medium with 10 ng/ml EGF and 
10
10 M cholera toxin, and subsequently lysed. Alternatively, cells were 
Table I.  Antibodies used for FACS
Antibodies Source
Anti-CD32 BD
Anti-CD45 BD
Anti- T cell receptor BD
Anti-CD11b eBioscience
Anti-Ly-6G eBioscience
1-A/1-E BD
Anti- cell receptor eBioscience
Anti-F4/80 Invitrogen
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For immunofluorescence analysis of cultured cells, cells were fixed for 
10 min with ice-cold acetone/methanol (1/1) and subsequently treated as 
described above for sections. Stained cells were photographed using a con-
focal microscope (SP1-2; Leica) equipped with a 63 × 0.6–1.32 NA (Iris) 
Plan-Apochromat oil objective lens. For data acquisition, we used the LCS 
Software (Leica).
For immunohistochemistry, biotinylated secondary antibodies (Vecta-
stain ABC kit; Vector Laboratories) and diaminobenzidine were used, fol-
lowed  by  counterstaining  with  hematoxylin.  Stained  sections  were 
photographed with a microscope (Axioskop 2) equipped with a camera 
(Axiocam HRc) and Plan-Neofluor (10×/0.3 NA, 20×/0.5 NA; all from 
Carl Zeiss, Inc.) objectives. For data acquisition, we used the Axiovision   
4.2 software (Carl Zeiss Inc.).
Antibodies used for immunofluorescence
See Table III for the antibodies used.
Staining of mast cells with toluidine blue
After deparaffination and rehydration, skin sections were stained with   
toluidine blue solution (0.5% toluidine blue and 0.5 N HCl, pH 2.3) for   
30 min. They were then washed with distilled water, dehydrated by a short 
incubation in 95% ethanol and two short incubations in 100% ethanol, and 
incubated twice for 3 min in xylene. Sections were then mounted with   
resinous mounting medium. Mast cells appear violet or purple.
Treatment of mouse skin with moisturizing cream
Moisturizing  cream  containing  aluminum  hydroxychloride  and  glycerol   
(Excipial Protect; Spirig Pharma AG) was applied to one side of the back 
skin of adult K5-R1/R2 mice, and the other side was left untreated.
Treatment of mouse skin with acetone
Adult female wild-type mice (C57Bl/6 background) were shaved, and the 
skin was rinsed with water-soaked tissues. One flank of the back was treated 
with 10 acetone wipes using delipidized, acetone-soaked swabs. The other 
flank was treated in the same manner with water and used as a control.
Western blot analysis
Cells were lysed in 2× Laemmli buffer. Frozen tissue was homogenized in a 
buffer containing phosphatase and protease inhibitors (Beyer et al., 2008).
Protein lysates were separated by SDS-PAGE and transferred to nitrocel-
lulose filters. Antibody incubations were performed in 5% nonfat dry milk in 
three washes with PBST (1× PBS/0.1% Tween 20), slides were incubated at 
room temperature for 1 h with the Cy2- or Cy3-conjugated secondary anti-
bodies (Jackson ImmunoResearch Laboratories, Inc.) and 1 µg/ml DAPI 
as a counterstain, washed with PBST again, and mounted with Mowiol 
(Sanofi-Aventis). Sections were photographed using a microscope (Imager.
A1) equipped with a camera (Axiocam Mrm) and enhanced-contrast Plan-
Neofluar objectives (10×/0.3 NA, 20×/0.5 NA; all from Carl Zeiss, Inc.). 
For data acquisition, we used the Axiovision 4.6 software (Carl Zeiss, Inc.).
Table II.  Primers used for RT-PCR
Target gene Forward sequence Reverse sequence
FGFR1 5-CAACCGTGTGACCAAAGTGG-3 5-TCCGACAGGTCCTTCTCCG-3
FGFR2 5-ATCCCCCTGCGGAGACA-3 5-GAGGACAGACGCGTTGTTATCC-3
IL-1 5-ATGATCTGGAAGAGACCATCC-3 5-GGCAACTCCTTCAGCAACA-3
IL-1 5-CTGAAAGCTCTCCACCTC-3 5-TGCTGATGTACCAGTTGGGG-3
IL-1F8 5-GCCTGTCATTCTTAGCTTGAT-3 5-TGTCTACTTCCTTAAGCTGC-3
TNF 5-CCCCAATGTGTCCGTCGTG-3 5-GCCTGCTTCACCACCTTCT-3
Claudin 8 5-TCAGAATGCAGTGCAAGGTC-3 5-AGCCGGTGATGAAGAAGATG-3
Claudin 3 5-GCGGCTCTGCTCACCTTAGT-3 5-GACGTAGTCCTTGCGGTCGTA-3
Claudin 1 5-CTTCTCTGGGATGGATCG-3 5-GGGTTGCCTGCAAAGTACTGT-3
Occludin 5-TTGAAGTCCACCTCCTTACAGA-3 5-CCGGATAAAAAGAGTACGCTGG-3
SPRR2a 5-GAACCTGATTCTGAGACTCAA-3 5-GCACACTACAGGACGACAC-3
S100A8 5-GCCGTCTGAACTGGAGAAG-3 5-GTGAGATGCCACACCCACTTT-3
S100A9 5-CGCAGCATAACCACCATCAT-3 5-AAGATCAACTTTGCCATCAGC-3
HGF 5-ACTTGCAAGGCCTTCG-3 5-GCAAAAAGCTGTGTTCATGGG-3
TGF- 5-CTGAGTGACTCACCCGTGGC-3 5-GCGGAGCTGACAGCAGTGGAT-3
ICAM-1 5-TGTTTCCTGCCTCTGAAGC-3 5-CTTCGTTTGTGATCCTCCG-3
G-CSF 5-TGCACTATGGTCAGGACGAG-3 5-GGGGTGACACAGCTTGTAGG-3
Vimentin 5-CCTGTACGAGGAGGAGATGC-3 5-GTGCCAGAGAAGCATTGTCA-3
Keratin 14 5-AACCACGAGGAGGAAATGG-3 5-CCGGAGCTCAGAAATCTCAC-3
TcR-V3 5-GGGTCGACTCCTGGATATCTCAGGATCAG-3 5-GGGTCGACTTGTTTCAGCAGAAGAAGGAAG-3
GAPDH 5-TCGTGGATCTGACGTGCCGCCTG-3 5-CACCACCCTGTTGCTGTAGCCGTAT-3
RPS29 5-GGTCACCAGCAGCTCTACTG-3 5-GTCCAACTTAATGAAGCCTATGTCC-3
HGF, hepatocyte growth factor; ICAM-1, intercellular adhesion molecule 1; TCR, T cell receptor.
Table III.  Antibodies used for immunofluorescence
Primary antibody Host Source
Anti-CD3 IgG Rabbit DAKO
Anti-Ly6G IgG Rat BD 
Anti-F4/80 IgG Rat BMA Biomedicals
Anti-keratin 6 IgG Rabbit Covance
Anti-keratin 10 IgG Mouse DAKO
Anti-keratin 14 IgG Rabbit Covance
Anti-filaggrin IgG Rabbit Covance
Anti-loricrin IgG Rabbit Covance
Anti-claudin3 IgG Rabbit Invitrogen
Anti-BrdU IgG-POD Mouse Roche
Anti--TCR IgG Hamster BD 
Anti-PCNA IgG Rabbit Santa Cruz Biotechnology, Inc.
Anti-CD45 Rat BD
Secondary antibody
Anti–mouse-Cy3 IgG Goat Jackson ImmunoResearch 
Laboratories, Inc.
Anti–rabbit-Cy2 IgG Goat Jackson ImmunoResearch 
Laboratories, Inc.
Anti–rabbit-Cy3 IgG Goat Jackson ImmunoResearch 
Laboratories, Inc.
Anti–rat-Cy3 IgG Donkey Jackson ImmunoResearch 
Laboratories, Inc.
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